Evidence map›Paper›PMID 35658531›Full record

ArticleJournal of virology2022

Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.

Xiaochun Chen, Jingzhi Li, Lan Yang, Yuxi Zhou, Mengyu Li, Wenwen Xu, Yixian Qin, Jia Su, Wei Zhao, Chaoyi Gu and 4 more

Abstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Detection of ongoing asymptomaticFrontiers in microbiology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaochun Chen *China Institute of Veterinary Drug Control, Beijing, China.
Jingzhi Li *Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Lan YangDivision of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Yuxi ZhouDivision of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Mengyu LiDivision of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Wenwen XuDivision of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Yixian QinChina Institute of Veterinary Drug Control, Beijing, China.
Jia SuChina Institute of Veterinary Drug Control, Beijing, China.
Wei ZhaoChina Institute of Veterinary Drug Control, Beijing, China.
Chaoyi GuSuzhou Qiangdong Biotechnology Co. Ltd., Suzhou, China.
Shuixing ShengSuzhou Animal Husbandry and Veterinary Station, Suzhou, China.
Yongfei PanGuangdong Wen's Group Academy, Yunfu, China.
Qinghong XueChina Institute of Veterinary Drug Control, Beijing, China.
Hongwei MaDivision of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.ORCID 0000-0003-4214-7142

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiation of infected from vaccinated hosts (DIVH) is a critical step in virus eradication programs. DIVH-compatible vaccines, however, take years to develop, and are therefore unavailable for fighting the sudden outbreaks that typically drive pandemics. Here, we establish a protocol for the swift and efficient development of DIVH assays, and show that this approach is compatible with any type of vaccines. Using porcine circovirus 2 (PCV2) as the experimental model, the first step is to use Immunoglobin G (IgG) sero-dynamics (IsD) curves to aid epitope discovery (IsDAED): PCV2 Cap peptides were categorized into three types: null interaction, nonspecific interaction (NSI), and specific interaction (SI). We subsequently compared IsDAED approach and traditional approach, and demonstrated identifying SI peptides and excluding NSI peptides supports efficient diagnostic kit development, specifically using a protein-peptide hybrid microarray (PPHM). IsDAED directed the design of a DIVH protocol for three types of PCV2 vaccines (while using a single PPHM). Finally, the DIVH protocol successfully differentiated infected pigs from vaccinated pigs at five farms. This IsDAED approach is almost certainly extendable to other viruses and host species.

Indexed as

Antibodies, ViralCircoviridae InfectionsEpitopesImmunoglobulin GViral VaccinesAnimalsCircovirusCOVID-19Disease Models, AnimalHumansPeptidesSARS-CoV-2SwineSwine DiseasesAntibodies, ViralEpitopesImmunoglobulin GPeptidesViral Vaccinesdiagnosisdifferentiation of infected from vaccinated hostsImmunoglobin G sero-dynamics curvelinear epitope identificationporcine circovirus 2

Identifiers

PMID35658531
PMCPMC9278109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.